Moving Away From Ritonavir, Abacavir, Tenofovir, and Efavirenz (RATE) - Agents That Concern Prescribers and Patients: A Feasibility Study and Call for a Trial
PLoS ONE - United States
doi 10.1371/journal.pone.0099530
Full Text
Open PDFAbstract
Available in full text
Categories
Date
June 26, 2014
Authors
Publisher
Public Library of Science (PLoS)